Skip to content
Stock screener

MGRX Mangoceuticals, Inc. stock chart & analysis

Conviction 40Scan · Wed, Nov 18, 2026

Mangoceuticals, Inc. (MGRX) closed at $0.1461 (-8.69%) on Nov 18, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 25, RS Rating 4, -89.4% from its 52-week high, -80.3% year to date. Sector: Services-Misc Health & Allied Services, NEC.

MGRX$0.1461-8.69%
ResistanceSupportVol 14
Loading chart…

Why MGRX moved

From the StockSetups movers recaps that covered MGRX, newest first. A recap states what was known that day.

Mangoceuticals, Inc.Services-Misc Health & Allied Services, NECwww.mangoceuticals.com ↗
Price0.1461
Change-8.69%
Gap-1.88%
Rel volume—
Avg volume894.76K
Avg $ vol171.6K
SMA 200.2073
SMA 500.3261
SMA 2000.3876
Price vs 50-55.20%
Price vs 200-62.30%
MA stackbearish
50/200 cross—
Supertrenddown · 0.2312
RSI (14)25
MACD hist0.00
MACD crossbull · 1d
Stoch %K / %D1 / 6
ADX (14)50
+DI / −DI6 / 33
RSI divergence—
MACD divergence—
ATR %20.49%
ADR %13.63%
52w high1.38
52w low0.1446
From 52w high-89.41%
Above 52w low+1.04%
New 52w highNo
SqueezeOff
Bollinger width65.89%
%B0.05
Donchian pos0.93%
Donchian high0.3051
Donchian low0.1446
AVWAP (52w high)0.5465
vs AVWAP high-73.27%
AVWAP (52w low)0.1492
vs AVWAP low-2.10%
OBV trendDown
Chaikin MF (20)-0.41
Today vs 20d—
Avg vol (14d)1.11M
Avg vol (20d)894.76K
Avg $ vol (20d)171.6K
Market cap—
RS Rating4 / 99
RS 3m (vs SPY)-57.89%
RS 6m (vs SPY)-64.31%
RS line new highNo
Trend template0/8
Technical rank7.0
1 week-26.69%
1 month-51.30%
3 months-62.12%
6 months-65.78%
1 year-88.40%
YTD-80.26%
P/E-0.17
P/B0.31
P/S—
P/FCF-0.60
EPS-2.17
Div yield—
ROE-186.30%
ROA-136.64%
Debt/Eq—
Current1.28
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-137.11%
Price target—
Target upside—
Analyst rating—
Institutional5.43%
Ent. value2.83M
Revenue69.5K
Net income-3.55M
Gross profit38.4K
Free cash flow-5.85M
IndustryServices-Misc Health & Allied Services, NEC
ExchangeNasdaq
Shares out17.17M
Employees—
ListedTue, Mar 21, 2023
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction40 / 100
Pattern quality—
Tech rank7.0 / 100
Group rank—
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.4990
Support0.1673
Days since event—
Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

MGRX technical analysis

Trend

MGRX is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 55.2% below the 50-day ($0.3261) and 62.3% below the 200-day ($0.3876). ADX(14) at 50 points to a strong, established trend. It meets 0 of 8 trend-template criteria.

Momentum

RSI(14) is 25, in oversold territory. MACD crossed above its signal line one session ago. Its RS Rating of 4 puts its weighted 12-month performance ahead of about 4% of the US market.

Volume and volatility

It trades about $171,601 a day on average. ATR(14) is $0.0299, 20.5% of price — its typical daily range. On-balance volume is trending down. Chaikin Money Flow (-0.41) shows distribution.

Key levels

The chart pattern's support is $0.1673 and its resistance $0.4990. The 52-week range is $0.1446 to $1.38; price is 89.4% below the high and 1.0% above the low. The VWAP anchored at the 52-week high is $0.5465, above price.

Performance

MGRX returned -26.7% (1 week), -51.3% (1 month), -62.1% (3 months), -65.8% (6 months), -88.4% (1 year), -80.3% (year to date).

About Mangoceuticals, Inc.

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Services-Misc Health & Allied Services, NEC · Listed 2023

SEC filings

EDGAR filings in MGRX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.